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POLICY BRIEF
About this research
Previous research* by the University of Bath’s Tobacco Control Research Group (TCRG) concluded that 
transnational tobacco companies (TTCs) advocated the introduction of ‘Better Regulation’, anticipating 
that it would make it harder for governments to enact public health policies. This research builds upon 
those conclusions, exploring how TTCs used the public consultation and impact assessment required 
by ‘Better Regulation’ to oppose standardised packaging of tobacco products in the UK.
Tobacco smoking kills one in two long-term users, and 207,000 children are estimated to take up 
smoking each year. Standardised packaging aims to reduce the impact of smoking on health by 
eliminating TTCs’ last remaining marketing opportunities. Under the measure, all packs will be printed 
in a drab brown colour, without logos, brand imagery or promotional text. A large body of peer-reviewed 
research shows that this measure is likely to both reduce the appeal of cigarettes among young people 
and increase the effectiveness of health warnings, thereby contributing to reducing smoking rates.  
The research examines TTCs’ attempts to use ‘Better Regulation’ processes to prevent the introduction 
of standardised packaging in the UK. It documents the quality and relevance of evidence cited by four 
TTCs – British American Tobacco, Imperial Tobacco Group, Japan Tobacco International and Philip 
Morris International – in their submissions to a public consultation on standardised packaging held 
in the UK in 2012. It critically examines the techniques they use to misrepresent evidence supporting 
standardised packaging and the quality of their data on the illicit tobacco trade. 
Research findings in context 
Independent research into standardised packaging has 
consistently found that there is strong evidence that the 
measure will reduce the appeal of tobacco products and 
increase the prominence of health warnings, and that there 
is no indication that standardised packaging is easier to 
counterfeit (Moodie et al., 2012).   
In their submissions to the 2012 consultation, TTCs 
contested these arguments and cited an alternative body 
of evidence, much of which was commissioned by them, 
to claim that standardised packaging would not have 
discernible health benefits, would boost the illicit trade 
in tobacco and would have a negative impact on the 
economy. The TCRG’s research, which examined this 
body of TTC-cited evidence, demonstrates that tobacco 
companies’ arguments against standardised packaging 
were unfounded, that their critiques of peer-reviewed 
public health evidence were highly misleading, and that 
their data and reports on the illicit trade in tobacco cannot 
be trusted.  
Yet, a fourteen month hiatus in the policy process followed 
the consultation.  During this time, the four TTCs attended 
meetings with Department of Health officials to provide 
additional evidence on impacts of the proposed policy 
and the Government announced a decision to ‘wait and 
see’ what evidence emerged from Australia, where a 
standardised packaging law had been introduced in 2012.  
Pressure from the House of Lords prompted a reopening 
of the policy debate and the Government commissioned 
an independent review of the evidence in November 
2013. This review fully endorsed the public health benefits 
of standardised packaging, questioned the validity of 
industry arguments and evidence and maintained that legal 
enforcement is sufficient and effective in mitigating the illicit 
trade in tobacco in the UK (Chantler, 2014).  A subsequent 
report from HMRC indicated there is no evidence to 
suggest standardised packaging would have a significant 
impact on the size of the illicit market (HMRC, 2014). 
Key findings
•	 TTCs invested significant resources in 
commissioning and disseminating research 
to support their two main arguments against 
standardised packaging; that it would 
not work, and that it would have negative 
consequences for the economy and the illicit 
trade in tobacco products.   
•	 This research was of significantly lower quality 
than research supporting the measure. For 
example, tobacco companies’ arguments were 
not supported by any peer-reviewed journal 
articles about standardised packaging. 
•	 In their submissions to the stakeholder 
consultation in 2012, tobacco companies: 
o Relied heavily on their commissioned  
 evidence and the opinions of third parties  
 with links to the tobacco industry to  
 support their position; 
o Used techniques, such as misquoting,  
 to encourage government and the public  
 to question the quality of the evidence  
 supporting standardised packaging;  
o Failed to include evidence showing the  
 central importance of packaging in  
 marketing their products; evidence which  
 is present in internal tobacco company  
 documents made public via litigation; and 
o Did not consistently and transparently  
 disclose their links to the evidence they  
 cited – for example, 91% of TTCs’ links to  
 evidence on illicit tobacco trade and  
 economic impacts of standardised  
 packaging were undisclosed. 
•	 Data on the illicit tobacco trade commissioned 
by tobacco companies markedly exaggerated 
its scale in the UK, and suggested that use 
of illicit tobacco was increasing despite 
independent data showing it was in decline. 
This is important because TTCs’ opposition to 
standardised packaging relied heavily on the 
argument that the policy would make tobacco 
products easier to counterfeit and would fuel 
the illicit trade.  
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The incentive for business to produce evidence to 
support their policy position and the battle over 
the quality of evidence in this policy debate would 
appear to be a consequence of the introduction of 
‘Better Regulation’ processes. ‘Better Regulation’ 
aims to prioritise business interests in the policy 
making process and to reduce regulatory costs to 
business. This is operationalised via a requirement 
to conduct public consultations and impact 
assessments, which afford business an incentive to 
commission favourable evidence and a privileged 
opportunity to present this ‘evidence’, lobby policy 
makers and have that evidence heard. Through 
these processes, TTCs sought to prevent, or at 
least delay, tobacco packaging regulation. Their 
submissions to the public consultation in 2012 made 
explicit references to the requirements of ‘Better 
Regulation’, and leaked documents from Philip 
Morris International show that the company had 
identified evidence-based policy making and ‘Better 
Regulation’ processes as key tools and mechanisms 
for opposing standardised packaging. 
Although standardised packaging legislation was 
eventually passed in March 2015, the slow pace 
of what became a three year policy process would 
suggest that the TTCs’ strategy was successful 
in at least delaying a policy decision. This finding, 
combined with previous evidence that TTCs 
advocated the introduction of ‘Better Regulation’ 
in order to make it harder for governments to 
enact public health policies, and their strategic 
use of evidence-based policy making and ‘Better 
Regulation’ in their efforts to oppose standardised 
packaging, raises questions about the opportunities 
‘Better Regulation’ processes give them to influence 
public health policy.  
 
Implications for policy
The TCRG’s research into standardised packaging 
shows that ‘Better Regulation’ processes intended 
to enhance evidence-based policy making may 
actually undermine it, enabling corporate interests to 
misrepresent evidence in order to create confusion, 
doubt and delay. 
‘Better Regulation’ affords TTCs a formal opportunity 
to engage in dialogue with government. This 
opportunity runs in direct contradiction to the 
commitment made by the 180 states, including the 
UK, that are party to the Framework Convention on 
Tobacco Control, to “protect” public health policies 
from “commercial and other vested interests of the 
tobacco industry”. ‘Better Regulation’ also adds 
legitimacy to TTCs’ counter argument that they ought 
to be involved in decisions which affect them.  
This research on standardised packaging highlights 
three ways to reduce the vulnerability of public health 
policy to diametrically opposed commercial interests:
•	 Increase transparency by making it a mandatory 
requirement to declare all relevant conflicts of 
interest in submissions to public consultations. 
This requirement should extend to the disclosure 
of any funding for individuals and organisations 
making submissions and of ‘experts’ and research 
mentioned or cited in submissions. Where 
corporations are found to have omitted such 
disclosures, governments should not be required to 
consider this evidence in their policy deliberations. 
•	 Increase governmental transparency by 
publishing and implementing clear guidelines 
on how submissions to public consultations, 
and evidence cited within, should be managed 
by policy makers. For example, a process for 
classifying evidence according to subject matter, 
independence and peer-review status could be 
used to enable the prioritisation of good quality, 
policy-focused evidence, and the identification 
of evidence which should be received more 
sceptically. 
•	 Review methods and structures for obtaining 
data on the illicit tobacco trade by exercising 
caution with regard to industry data and rejecting 
collaborations with industry to obtain data; by 
requiring industry reports on the illicit trade to 
describe methods transparently and be subject 
to independent peer-review before being made 
public; and by commissioning independent 
research into the scale of the illicit tobacco trade.
Methodology
The TCRG’s research entailed analysis of TTCs’ 
submissions to the public consultation, TTC-
commissioned reports and TTC data cited in the 
media. The different studies variously employed 
quantitative content analysis, qualitative interpretive 
analysis and detailed methodological review. Where 
appropriate, iterative agreement of codes and 
multiple coders were used to ensure inter-coder 
reliability, and statistical analyses (Fisher’s exact 
tests) were used to compare the quality of industry 
and independent research and data.
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